scholarly journals Elastography as a predictor of liver cirrhosis complications after hepatitis C virus eradication in the era of direct-acting antivirals

2021 ◽  
Vol 13 (11) ◽  
pp. 1663-1676
Author(s):  
Lucia Cerrito ◽  
Maria Elena Ainora ◽  
Alberto Nicoletti ◽  
Matteo Garcovich ◽  
Laura Riccardi ◽  
...  
Keyword(s):  
Liver Cirrhosis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Direct Acting Antivirals ◽  
Virus Eradication ◽  
Direct Acting

scholarly journals Direct-acting antivirals and hepatocellular carcinoma occurrence and recurrence in hepatitis C virus-related liver cirrhosis: fact or finction

2018 ◽  
Vol 4 (11) ◽  
pp. 70
Author(s):  
Alberto Zanetto ◽  
Sarah Shalaby ◽  
Alberto Ferrarese ◽  
Chiara Becchetti ◽  
Salvatore Sciarrone ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Cirrhosis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Direct Acting Antivirals ◽  
Direct Acting

Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis

2018 ◽  
Vol 48 (11-12) ◽  
pp. 1301-1311 ◽  
Author(s):  
Francesca Romana Ponziani ◽  
Lorenza Putignani ◽  
Francesco Paroni Sterbini ◽  
Valentina Petito ◽  
Anna Picca ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Gut Microbiota ◽  
Direct Acting Antivirals ◽  
Virus Eradication ◽  
Direct Acting

scholarly journals The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses

Viruses ◽  
2020 ◽  
Vol 12 (3) ◽  
pp. 302
Author(s):  
Eui-Cheol Shin ◽  
Ji Won Han ◽  
Wonseok Kang ◽  
Takanobu Kato ◽  
Seong-Jun Kim ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Cirrhosis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
International Symposium ◽  
Virologic Response ◽  
Direct Acting Antivirals ◽  
Chronic Hcv Infection ◽  
Chronic Hcv ◽  
Direct Acting

Hepatitis C virus (HCV) infects ~71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma. The use of direct-acting antivirals results in a sustained virologic response in >95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5–8, 2019, virologists, immunologists, and clinical scientists discussed these remaining issues and how we can achieve the elimination of HCV.

Sign in / Sign up

Export Citation Format

Share Document